KUALA LUMPUR: AmInvestment Research has upgraded Salutica to “buy” from “sell” with a higher fair value of 61 sen a share (previously 20 sen).
The research house has also doubled its FY20F-FY21F net profit due to new catalysts from the trade diversion and Customer A’s product regaining positive traction after fixing a connectivity issue.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!